Glutathione is a tripeptide, which is just a fancy way of saying it's made from three amino acid building blocks: Cysteine Glycine Glutamic acid Your liver handles most of the production of glutathione, and this powerful antioxidant exists in nearly every cell
reconstituted peptide drug candidates remain viable for longer periods, extending the effective life of solutions used across days, weeks, or even months of an experimental cycle
The ChEMBL drug registry records tirzepatide at maximum phase 4 (approved), first approval 2022, parenteral, with a first-in-class GIP-agonist designation and a boxed-warning flag
Published studies in rodent models have documented effects on tendon-to-bone healing, ligament recovery, muscle crush injury recovery, and gastrointestinal mucosal integrity